TY  - GEN
AU  - Tamareille,Sophie
AU  - Ghaboura,Nehmat
AU  - Treguer,Frederic
AU  - Khachman,Dalia
AU  - Croué,Anne
AU  - Henrion,Daniel
AU  - Furber,Alain
AU  - Prunier,Fabrice
TI  - Myocardial reperfusion injury management: erythropoietin compared with postconditioning
SN  - 1522-1539
PY  - 2010///0217
KW  - Animals
KW  - Cardiotonic Agents
KW  - therapeutic use
KW  - Coronary Circulation
KW  - drug effects
KW  - Darbepoetin alfa
KW  - Disease Models, Animal
KW  - Erythropoietin
KW  - analogs & derivatives
KW  - Female
KW  - Glycogen Synthase Kinase 3
KW  - metabolism
KW  - Glycogen Synthase Kinase 3 beta
KW  - Heart Rate
KW  - Mitogen-Activated Protein Kinase 1
KW  - antagonists & inhibitors
KW  - Mitogen-Activated Protein Kinase 3
KW  - Myocardial Infarction
KW  - enzymology
KW  - Myocardial Reperfusion Injury
KW  - Myocardium
KW  - Phosphatidylinositol 3-Kinases
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Phosphorylation
KW  - Protein Kinase Inhibitors
KW  - pharmacology
KW  - Proto-Oncogene Proteins c-akt
KW  - Rats
KW  - Rats, Wistar
KW  - Time Factors
KW  - Ventricular Function, Left
KW  - Ventricular Pressure
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1152/ajpheart.00472.2009
ER  -